Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Not Determined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01837121
What this trial is testing

A Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Who this might be right for
ComplianceDiabetic RetinopathySMS
Sun Yat-sen University 237
Early research (Phase 1)Study completedNCT06493045
What this trial is testing

First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IRL757 in Healthy Volunteers

Who this might be right for
Not Determined
Integrative Research Laboratories AB 82
Testing effectiveness (Phase 2)UnknownNCT01577784
What this trial is testing

Pazopanib in Second-line Therapy in Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain 27
Testing effectiveness (Phase 2)WithdrawnNCT05664893
What this trial is testing

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne
Not applicableStudy completedNCT00002310
What this trial is testing

SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals
Early research (Phase 1)Study completedNCT05093270
What this trial is testing

First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants

Who this might be right for
Not Determined
BeiGene 92
Not applicableUnknownNCT04712409
What this trial is testing

Surgical Innovation for Diabetes Treatment 2

Who this might be right for
Enteroendocrine Physiological Changes in Superobese Patients Submitted to Two Different Bariatric ProceduresDetermine Whether BPD With DS or SADI-S as Primary or Revisional Surgery is Superior Than the Other as First Choice for the SuperobeseDetermine Whether or Not Revision Surgery is as Effective as Primary Surgery and Understand the Physiological Mechanisms Inherent in These Putative Differences
Hospital de Sao Sebastiao
Not applicableStudy completedNCT00908011
What this trial is testing

Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets

Who this might be right for
HypercholesterolemiaHIV Infections
University of British Columbia 43
Large-scale testing (Phase 3)Looking for participantsNCT07184619
What this trial is testing

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA 400
Not applicableStudy completedNCT04518969
What this trial is testing

Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19

Who this might be right for
Covid19
Dr David DE BELS 24
Large-scale testing (Phase 3)Study completedNCT02352948
What this trial is testing

A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non - Small Cell Lung Cancer NSCLC
AstraZeneca 597
Not applicableStudy completedNCT05762718
What this trial is testing

Validation of a Food Frequency Questionnaire: VioScreen

Who this might be right for
Not Determined
University of Colorado, Denver 27
Testing effectiveness (Phase 2)Study completedNCT01455090
What this trial is testing

Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 320
Large-scale testing (Phase 3)Study completedNCT00270075
What this trial is testing

Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

Who this might be right for
Blood TransfusionBlood Transfusion, AutologousOrthopedic Procedures+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03484702
What this trial is testing

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 113
Not applicableNot Yet RecruitingNCT06797570
What this trial is testing

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

Who this might be right for
Attention Deficit DisorderAttention Deficit Disorder (ADD)Attention Deficit Disorder with Hyperactivity+13 more
St. Antonius Hospital
Early research (Phase 1)Ended earlyNCT01548924
What this trial is testing

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Centro Nacional de Investigaciones Oncologicas CARLOS III 13
Testing effectiveness (Phase 2)Study completedNCT00045422
What this trial is testing

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT00547599
What this trial is testing

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Who this might be right for
Impotence
Eli Lilly and Company 659
Next Page
40
130